TUDCA: What the Science Says About This Trending Supplement

Written By Ingrid Huddleston

You may have seen TUDCA supplements gaining attention online, praised for a wide range of health benefits. But what exactly is it, and what does the science say? Let’s break down what you need to know about this intriguing compound.

Tauroursodeoxycholic acid, or TUDCA, is a special type of bile acid that your body produces in small amounts. It has been used for centuries in traditional medicine and is now being studied for its potential health applications.

How Does It Work?

At its core, TUDCA is a cell protector. Think of it as a support crew for your cells. When cells experience stress, their internal machinery can get overwhelmed, leading to damage and malfunction. TUDCA steps in to help reduce this stress, particularly in the part of the cell that builds proteins. By easing this burden, it helps cells function correctly and protects them from self-destructing, a process linked to many chronic conditions.

What Are the Research-Backed Benefits?

While TUDCA is studied for many conditions, human clinical research provides the strongest evidence for a few key areas:

  • Liver Health: This is TUDCA’s most established benefit. It is an approved medical treatment in some countries for specific liver conditions where bile flow is impaired, such as Primary Biliary Cholangitis (PBC). A major clinical trial found it was as effective as the standard treatment for improving liver enzymes in PBC patients.

  • Metabolic Support: TUDCA shows significant promise for metabolic health. In a clinical trial with obese individuals, taking TUDCA for just four weeks improved both liver and muscle insulin sensitivity by approximately 30%, an effect comparable to some anti-diabetic medications.

Research into other areas, like neuroprotection for diseases such as Alzheimer's or Parkinson's, is ongoing but currently limited to preclinical or early-stage studies. A large, high-quality trial for ALS unfortunately found that TUDCA was not effective at slowing the disease.

Who Might Benefit and Is It Safe?

Based on current evidence, TUDCA may be most relevant for individuals with specific cholestatic liver diseases (under a doctor’s supervision) or those looking to support their metabolic health and insulin sensitivity.

TUDCA is generally considered safe and well-tolerated in clinical trials. The most common side effects are mild and related to digestion, such as diarrhea or an upset stomach. However, due to a lack of research, it should be avoided by those who are pregnant or breastfeeding. It can also interact with certain medications, so it is essential to speak with a healthcare professional before adding it to your routine.

The Bottom Line

TUDCA is a fascinating compound with strong evidence supporting its use for specific liver conditions and promising data for improving insulin sensitivity. As with any supplement, it’s important to look at the science and consult with a trusted healthcare provider to see if it’s a good fit for your personal health plan.

  • TUDCA (tauroursodeoxycholic acid) is a bile acid your body naturally produces in small amounts. It helps protect cells from stress, particularly in the endoplasmic reticulum, which is responsible for protein folding. This protective function supports healthy liver function and may influence metabolic and cellular health.

  • Current human research highlights two key areas of benefit:

    • Liver health: TUDCA is an approved treatment in some countries for cholestatic liver diseases like Primary Biliary Cholangitis (PBC), improving bile flow and liver enzyme levels.

    • Metabolic support: In clinical trials, TUDCA improved insulin sensitivity in the liver and muscles by around 30%, offering potential support for metabolic health.

  • Yes. TUDCA is most well-established as a liver support compound. It helps improve bile flow and reduce liver enzyme levels in people with certain liver diseases. It’s sometimes prescribed as a treatment for Primary Biliary Cholangitis and related conditions.

  • Yes. A clinical trial found that TUDCA supplementation improved insulin sensitivity in obese individuals within just four weeks. The effect was comparable to some prescription medications used to treat insulin resistance.

  • Research is ongoing. Preclinical studies suggest TUDCA may protect brain cells and reduce neuroinflammation. However, human trials are limited and results have been mixed—one large ALS trial, for example, found no benefit. More research is needed before conclusions can be made.

  • TUDCA may be helpful for:

    • Individuals with cholestatic liver conditions (under medical supervision)

    • People seeking to support insulin sensitivity or metabolic health

    • Those experiencing cellular stress from chronic inflammation or metabolic imbalance

  • TUDCA is generally safe and well-tolerated. Mild digestive symptoms such as diarrhea or stomach upset may occur. It is not recommended during pregnancy or breastfeeding and should not be combined with certain medications without medical guidance.

Works Cited

  1. Tauroursodeoxycholic Acid (TUDCA) - Alzheimer's Drug Discovery Foundation, accessed June 27, 2025, https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Tauroursodeoxycholic-Acid-Cognitive-Vitality-For-Researchers.pdf

  2. Tauroursodeoxycholic acid: Uses, Interactions, Mechanism of Action | DrugBank Online, accessed June 27, 2025, https://go.drugbank.com/drugs/DB08834

  3. Tauroursodeoxycholate—Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives - PubMed Central, accessed June 27, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6952947/

  4. The Unexpected Uses of Urso- and Tauroursodeoxycholic Acid in the Treatment of Non-liver Diseases - PubMed Central, accessed June 27, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4030606/

  5. (PDF) Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: A double-blind randomized controlled trial - ResearchGate, accessed June 27, 2025, https://www.researchgate.net/publication/236206558_Efficacy_and_safety_of_tauroursodeoxycholic_acid_in_the_treatment_of_liver_cirrhosis_A_double-blind_randomized_controlled_trial

  6. Tauroursodeoxycholic acid - MND Association, accessed June 27, 2025, https://www.mndassociation.org/research/clinical-trials/treatment-trials/tudca

  7. Tauroursodeoxycholic acid | C26H45NO6S | CID 9848818 - PubChem, accessed June 27, 2025, https://pubchem.ncbi.nlm.nih.gov/compound/Tauroursodeoxycholic-acid

  8. Tauroursodeoxycholate—Bile Acid with Chaperoning Activity ... - MDPI, accessed June 27, 2025, https://www.mdpi.com/2073-4409/8/12/1471

  9. Research Breakdown on TUDCA - Examine - Examine.com, accessed June 27, 2025, https://examine.com/supplements/tudca/research/

  10. Ursodoxicoltaurine - Wikipedia, accessed June 27, 2025, https://en.wikipedia.org/wiki/Ursodoxicoltaurine

  11. What is Tudca? | Information & Faq - Everyone.org, accessed June 27, 2025, https://everyone.org/blog/tudca-information

  12. Neuroprotective Effect of Tauroursodeoxycholic Acid (TUDCA) on In Vitro and In Vivo Models of Retinal Disorders: A Systematic Review - PubMed Central, accessed June 27, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11092919/

  13. Study Details | Efficacy and Safety Study of TUDCA Compare UDCA ..., accessed June 27, 2025, https://clinicaltrials.gov/ct2/show/NCT01829698

  14. What Is TUDCA? | Gut Health and Anxiety - Harmony, accessed June 27, 2025, https://www.grwhealth.com/post/what-is-tudca-and-what-are-its-benefits/

  15. Administration of Tauroursodeoxycholic Acid Attenuates Early Brain Injury via Akt Pathway Activation - Frontiers, accessed June 27, 2025, https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2017.00193/full

  16. What Is TUDCA: Benefits & Supplementation - BodyBio, accessed June 27, 2025, https://bodybio.com/blogs/blog/what-is-tudca

  17. Tauroursodeoxycholic Acid (TUDCA): A Promising Neuroprotective Agent Derived from Bile Salts - Restorative Medicine, accessed June 27, 2025, https://restorativemedicine.org/digest/tauroursodeoxycholic-acid-tudca-promising-neuroprotective-agent-derived-bile-salts/

  18. Effect of a chemical chaperone, tauroursodeoxycholic acid, on HDM-induced allergic airway disease - American Journal of Physiology, accessed June 27, 2025, https://journals.physiology.org/doi/full/10.1152/ajplung.00396.2015

  19. Tauroursodeoxycholate (TUDCA), chemical chaperone, enhances function of islets by reducing ER stress | Request PDF - ResearchGate, accessed June 27, 2025, https://www.researchgate.net/publication/44666906_Tauroursodeoxycholate_TUDCA_chemical_chaperone_enhances_function_of_islets_by_reducing_ER_stress

  20. TUDCA modulates drug bioavailability to regulate resistance to acute ER stress in Saccharomyces cerevisiae - Molecular Biology of the Cell (MBoC), accessed June 27, 2025, https://www.molbiolcell.org/doi/10.1091/mbc.E24-04-0147

  21. TUDCA modulates drug bioavailability to regulate resistance to acute ER stress in Saccharomyces cerevisiae | bioRxiv, accessed June 27, 2025, https://www.biorxiv.org/content/10.1101/2024.11.14.623614v1

  22. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation - PubMed, accessed June 27, 2025, https://pubmed.ncbi.nlm.nih.gov/12198651/

  23. Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats | PNAS, accessed June 27, 2025, https://www.pnas.org/doi/10.1073/pnas.1031632100

  24. A multicenter, randomized, double-blind trial comparing the efficacy ..., accessed June 27, 2025, https://pubmed.ncbi.nlm.nih.gov/27893675/

  25. Tauroursodeoxycholic Acid Falls Short in Phase 3 Study of Amyotrophic Lateral Sclerosis, accessed June 27, 2025, https://www.neurologylive.com/view/tauroursodeoxycholic-acid-falls-short-phase-3-study-amyotrophic-lateral-sclerosis

  26. Results of TUDCA-study: No effect of investigated compound - TRICALS, accessed June 27, 2025, https://www.tricals.org/news/results-of-tudca-study-no-effect-of-investigated-compound

  27. Trial of Tauroursodeoxycholic Acid Supplementation in Patients with Progressive MS (S16.007) - Neurology.org, accessed June 27, 2025, https://www.neurology.org/doi/10.1212/WNL.0000000000203843

  28. Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not ..., accessed June 27, 2025, https://diabetesjournals.org/diabetes/article/59/8/1899/14430/Tauroursodeoxycholic-Acid-May-Improve-Liver-and

  29. Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women - PubMed, accessed June 27, 2025, https://pubmed.ncbi.nlm.nih.gov/20522594/

  30. Tauroursodeoxycholic Acid (TUDCA) Reduces ER Stress and Lessens Disease Activity in Ulcerative Colitis - PMC, accessed June 27, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11998832/

  31. Tauroursodeoxycholic Acid (TUDCA) Reduces ER Stress and Lessens Disease Activity in Ulcerative Colitis | medRxiv, accessed June 27, 2025, https://www.medrxiv.org/content/10.1101/2025.04.02.25322684v1

  32. Relationship: Hepatitis and Tauroursodeoxycholic Acid - Caring Sunshine, accessed June 27, 2025, https://caringsunshine.com/relationships/relationship-hepatitis-and-tauroursodeoxycholic-acid/

  33. Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis, accessed June 27, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5024041/

  34. Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol - PMC - PubMed Central, accessed June 27, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9552801/

  35. European study finds popular ALS drug ineffective | BioPharma Dive, accessed June 27, 2025, https://www.biopharmadive.com/news/als-tudca-trial-europe/711510/

  36. TUDCA Trial - International Alliance of ALS/MND Associations, accessed June 27, 2025, https://www.als-mnd.org/support-for-pals-cals/drugs-no-longer-development/tudca/

  37. Combination of tauroursodeoxycholic acid, co-enzyme ... - Frontiers, accessed June 27, 2025, https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2024.1492028/full

  38. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease | PNAS, accessed June 27, 2025, https://www.pnas.org/doi/10.1073/pnas.162362299

  39. Tauroursodeoxycholic acid: a bile acid that may be used for the prevention and treatment of Alzheimer's disease - Frontiers, accessed June 27, 2025, https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2024.1348844/full

  40. Positive results from an early clinical trial for a drug boosting cell batteries in people with Parkinson's, accessed June 27, 2025, https://www.parkinsons.org.uk/news/positive-results-early-clinical-trial-drug-boosting-cell-batteries-people-parkinsons

  41. The UP Study results - Cure Parkinson's, accessed June 27, 2025, https://cureparkinsons.org.uk/2023/06/up-study/

  42. Clinical Investigation of Efficacy of Tauroursodeoxycholic Acid (TUDCA) to Enhance Pancreatic Beta Cell Survival In - ClinicalTrials.gov, accessed June 27, 2025, https://cdn.clinicaltrials.gov/large-docs/19/NCT02218619/Prot_SAP_000.pdf

  43. Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes | ClinicalTrials.gov, accessed June 27, 2025, https://clinicaltrials.gov/ct2/show/NCT02218619

  44. Neuroprotective Effect of Tauroursodeoxycholic Acid (TUDCA) on In Vitro and In Vivo Models of Retinal Disorders: A Systematic Review - Li - Current Neuropharmacology, accessed June 27, 2025, https://rjeid.com/1570-159X/article/view/644871

  45. Neuroprotective Effect of Tauroursodeoxycholic Acid (TUDCA) on In Vitro and In Vivo Models of Retinal Disorders: A Systematic Review - PubMed, accessed June 27, 2025, https://pubmed.ncbi.nlm.nih.gov/37691227/

  46. TUDCA Slows Retinal Degeneration in Two Different Mouse Models of Retinitis Pigmentosa and Prevents Obesity in Bardet-Biedl Syndrome Type 1 Mice - PubMed Central, accessed June 27, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3292352/

  47. Tauroursodeoxycholic Acid (TUDCA) Protects Photoreceptors from Cell Death after Experimental Retinal Detachment | PLOS One, accessed June 27, 2025, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0024245

  48. Neuroprotective Effects of Tauroursodeoxicholic Acid Involves Vascular and Glial Changes in Retinitis Pigmentosa Model - Frontiers, accessed June 27, 2025, https://www.frontiersin.org/journals/neuroanatomy/articles/10.3389/fnana.2022.858073/full

  49. What are TUDCA's main drawbacks? - Examine.com, accessed June 27, 2025, https://examine.com/faq/what-are-tudcas-main-drawbacks/

  50. Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study, accessed June 27, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10570688/

  51. Study Details | TUDCA as a Therapy for Ulcerative Colitis (UC) | ClinicalTrials.gov, accessed June 27, 2025, https://clinicaltrials.gov/study/NCT04114292?term=eif2a&viewType=Table&checkSpell=&rank=2

  52. Record History | ver. 5: 2019-07-12 | NCT03800524 - ClinicalTrials.gov, accessed June 27, 2025, https://clinicaltrials.gov/study/NCT03800524?tab=history&a=5

  53. Safety and Efficacy of Tauroursodeoxycholic (TUDCA) as add-on Treatment in Patients Affected by Amyotrophic Lateral Sclerosis (ALS) | NEALS, accessed June 27, 2025, https://neals.org/als-trials/nct03800524

  54. TUDCA benefits, dosage, and side effects - Examine.com, accessed June 27, 2025, https://examine.com/supplements/tudca/

  55. What Are TUDCA Supplements? Exploring Benefits, Side Effects, and Safety - VitaRx, accessed June 27, 2025, https://www.vitarx.co/resources/fitness-energy/what-are-tudca-supplements

  56. Sodium phenylbutyrate and taurursodiol Uses, Side Effects ..., accessed June 27, 2025, https://www.drugs.com/mtm/sodium-phenylbutyrate-and-taurursodiol.html

Content Disclaimer

This information was generated and formatted using AI technology to summarize and present current scientific research on the specified supplement. While every effort has been made to ensure accuracy, clarity, and relevance, the information provided should not be considered a substitute for professional medical advice. All health claims are supported by citations from peer-reviewed studies and credible sources, which have been included for transparency and verification. Always consult a qualified healthcare provider before making decisions related to supplement use or health interventions.

Ingrid Huddleston
Previous

Curcumin Explained: A Simple Guide to Turmeric's Golden Compound
Next

Glycine: The Small Amino Acid with Big Health Benefits